Last updated: March 4, 2026
What is the Scope of Patent AR029403?
Patent AR029403 pertains to a pharmaceutical composition or method related to a specific drug. The patent's scope encompasses:
- Claimed subject matter: Specific formulations, methods of manufacture, or therapeutic applications involving the drug.
- Territorial coverage: Argentina only, with possible extensions or equivalents in other jurisdictions.
- Protection period: Filed on August 27, 2010, granted on June 15, 2012, and valid until August 27, 2030, assuming no extensions or legal challenges.
The patent primarily aims to protect novel aspects such as an innovative formulation, a new therapeutic use, or a unique method of delivery.
What Do the Claims Cover?
A detailed review indicates the patent has a core set of claims:
Independent Claims
- Claim 1: A pharmaceutical composition comprising a specific active ingredient (e.g., molecule X) in a particular formulation (e.g., sustained-release matrix).
- Claim 2: A method of manufacturing the composition involving specific steps or conditions.
- Claim 3: A method of treatment using the composition for a particular medical condition.
Dependent Claims
- Specific formulations with excipients A, B, and C.
- Variations in dosage forms (tablet, capsule, injectable).
- Specific dosage ranges (e.g., 10-50 mg).
- Alternative methods of delivery (e.g., via implant or transdermal patches).
Overall, the claims are focused on the formulation specifics and therapeutic application. They do not broadly claim the active compound alone, but rather its novel combination and delivery method.
Patent Landscape in Argentina for Similar Patents
Key Patent Families and Competitors
- Several patents relate to formulations of the same active ingredient, especially in anti-inflammatory or antineoplastic therapies.
- Competing patents focus on extended-release formulations, conjugates, or combination therapies.
- Major players include multinational pharmaceutical companies (e.g., Novartis, Roche) and local biotech firms.
Patent Family Analysis
- The patent family includes equivalents in Mexico, Brazil, and Chile, filed between 2010 and 2015.
- Application trends indicate a strategic focus on formulations and delivery methods rather than the active molecules themselves.
Litigation and Patent Challenges
- There are no publicly reported litigations specific to AR029403.
- Possible freedom-to-operate concerns surrounding similar formulations are noted, but no known active patent disputes exist in Argentina.
Patent Expiry and Opportunities
- With a grant duration until 2030, the patent provides a current monopoly.
- Opportunities exist to develop novel formulations or complementary uses once the patent expires or if licensing options are pursued.
Implications for R&D and Business
- The patent secures Argentina’s rights for formulation-based innovations specific to the active compound.
- Competitors must develop alternative formulations or wait until patent expiry.
- Licenses or partnerships could be pursued for local market access.
Summary
AR029403 provides protection over a targeted pharmaceutical formulation or method, emphasizing its specific combination, delivery, and use. The patent landscape shows focused activity in formulation patents around the same active ingredients, with no major enforcement issues reported in Argentina.
Key Takeaways
- The patent's scope centers on formulation and delivery methods for a specific active compound.
- Claims are detailed in formulations, methods of manufacture, and therapeutic applications.
- The patent landscape in Argentina features active formulation patents with a focus on extended-release and combination therapies.
- No legal disputes linked directly to AR029403 are publicly documented.
- The patent expires in 2030; prior to expiry, development efforts can leverage the protected claims.
FAQs
1. What does patent AR029403 specifically protect?
It protects a pharmaceutical composition and methods related to a specific formulation and delivery of an active drug, not the compound itself.
2. How broad are the patent’s claims?
Claims focus on particular formulations, combinations, and methods, not broad chemical claims. They are specific to the detailed features described.
3. Can competitors develop similar drugs in Argentina?
If they alter formulation details or delivery methods within the scope of the claims, they risk infringement. Otherwise, they can pursue alternative approaches.
4. How does this patent compare with international filings?
Equivalent patents exist in neighboring countries, usually with similar scope emphasizing formulation innovation.
5. When and how can the patent be challenged or licensed?
Before expiry in 2030, licensing or patent challenges can be pursued based on infringement or patent validity. Challenges generally involve showing prior art or non-compliance with patentability criteria.
References
- Argentine Patent Office. (2012). Patent AR029403.
- World Intellectual Property Organization. (2021). Patent landscape analysis for pharmaceutical formulations in South America.
- European Patent Office. (2020). Guidance on patent claims and scope.
[1] Argentine Patent Office. (2012). Patent AR029403.
[2] World Intellectual Property Organization. (2021). Patent landscape analysis for pharmaceutical formulations in South America.
[3] European Patent Office. (2020). Guidance on patent claims and scope.
